Walid Chayouâ

The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome

Walid Chayouâ, Hilde Kelchtermans, Jean‐Christophe Gris et al. · Journal of Thrombosis and Haemostasis · 2019 · 86 citations · Full text

Life Sciences, Hematology, Immunology +11

Identification of high thrombotic risk triple‐positive antiphospholipid syndrome patients is dependent on anti‐cardiolipin and anti‐β2glycoprotein I antibody detection assays

Walid Chayouâ, Hilde Kelchtermans, Gary Moore et al. · Journal of Thrombosis and Haemostasis · 2018 · 70 citations · Full text

Medicine, Hematology, Immunology +12

Semiquantitative interpretation of anticardiolipin and antiβ2glycoprotein I antibodies measured with various analytical platforms: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Arne Vandevelde, Walid Chayouâ, Bas de Laat et al. · Journal of Thrombosis and Haemostasis · 2021 · 65 citations · Full text

Life Sciences, Immunology, Pathology +12

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

Henri M.H. Spronk, Teresa Padró, Joylene E. Siland et al. · Thrombosis and Haemostasis · 2018 · 59 citations · Full text

Medicine, Cardiology, Pathobiology +17

Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms

Walid Chayouâ, Hilde Kelchtermans, Gary Moore et al. · Thrombosis and Haemostasis · 2019 · 48 citations · Full text

Pharmacy, Hematology, Immunology +15